Vi­a­tris with­draws ac­cel­er­at­ed ap­proval for top­i­cal an­timi­cro­bial 24 years lat­er

Af­ter 24 years with­out con­firm­ing clin­i­cal ben­e­fit, the FDA an­nounced Tues­day morn­ing that Vi­a­tris (formed via My­lan and Pfiz­er’s Up­john) has de­cid­ed to with­draw a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.